Cross-border innovation funding opportunities between Canada and the U.S.
Don’t miss the insights from our webinar : Cross-border innovation funding opportunities between Canada and the U.S. Originally aired on January 16th, 2026 In this webinar replay, our experts break down the key innovation funding programs in Canada and the U.S., including SR&ED, U.S. R&D Tax Credits, and grant opportunities supporting AI, growth, and international […]
Catalysts of Innovation : Tax incentives for Life Sciences companies
Don’t miss the insights from our webinar : Catalysts of Innovation : Tax incentives for Life Sciences companies Originally aired on January 14th, 2026 Laurent Lecanu, Director of the Life Sciences Cluster, North America at Leyton, breaks down the latest opportunities in funding, incentives, and financial strategies that can directly support your R&D and operational […]
Sales and Income Tax Nexus for SaaS: Protecting Your Valuation
For fast growing software and SaaS companies, tax compliance has become a critical part of operational readiness. Since the 2018 Wayfair ruling, states can require remote software sellers to collect and remit taxes based solely on economic nexus, even without physical presence. This shift has created a major blind spot for SaaS founders, CFOs, and […]
Filing Deadline 2026: Key R&D Tax Credit Dates
With the R&D tax credit Deadline 2026 fast approaching, many businesses risk leaving money on the table simply because they are unaware of the key dates that apply to them. 2025 was a year full of significant legislative updates and tax code changes, many of which impacted Leyton’s services in areas such as the Credit […]
Fueling Biotech Breakthroughs: R&D Tax Credits in Life Sciences
Innovation transforms biotech, the R&D Tax Credit ensures it also strengthens your bottom line. From protein engineering to CRISPR-based gene editing, biotechnology sits at the cutting edge of modern science. Every breakthrough, whether improving enzyme stability or designing a new therapeutic platform, stems from methodical experimentation rooted in biology, chemistry, and engineering. Yet, amid the […]
Regulatory Science and the R&D Tax Credit
Regulatory science forms the bridge between innovation and public safety, transforming complex discoveries into validated, approvable, and reproducible medical products. But as the field evolves, researchers are no longer just applying established methods; they’re developing new scientific frameworks, modeling approaches, and validation techniques that often involve true experimentation. Whether refining bioequivalence models, building predictive stability […]
2025 in Review: Key Tax & Industry Trends Shaping 2026
As we move into 2026, the strategy is no longer just about identifying tax credits, it’s about navigating a high-compliance environment where timing and domestic presence are the new currencies of innovation. In our recent year in review webinar, Leyton’s panel of experts, including: Cedric James | Director of Commercial Real Estate Devin Medrek | […]
R&D Tax Credit For Plastic Surgery and Restorative Medicine
Innovation lies at the heart of plastic surgery and restorative medicine, where practitioners continuously refine procedures, materials, and technologies to enhance patient outcomes and safety. Yet, many clinics and surgical centers remain unaware that their innovative efforts may qualify for the Research and Development (R&D) Tax Credit under U.S. law, a powerful incentive designed to […]
FEDERAL ALERT: SBIR and STTR Program Expiration
The landscape for American innovation has hit a sudden and significant roadblock. As of midnight on September 30, 2025, the legislative authority for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs officially lapsed. This SBIR and STTR program expiration has triggered immediate and severe consequences for federal innovation and commercialization […]
AI in Healthcare: Unlocking Innovation Through R&D Tax Credits
For early-stage healthcare technology companies, cash is as critical as it is scarce. Developing AI solutions for diagnostics, predictive analytics, patient monitoring, and drug discovery requires significant R&D investment, often before meaningful revenue is realized. Federal and state R&D tax credits provide an essential mechanism to extend runway, reduce fundraising pressure, and reinvest in innovation. […]